FDA Investigator: Kevin A. Gonzalez
- Kevin A. Gonzalez first started conducting FDA inspections in 2002, with the last inspection in 2015. Over that time, Kevin A. Gonzalez has conducted 153 inspections at 128 companies across 134 sites.
Get Kevin Gonzalez's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Fresenius Kabi USA, Grand Island | July 2011
Available Now - $199
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Ohm Laboratories, Gloversville | August 2009
Available Now - $199
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Fujian Kerui Pharmaceutical Co., Ltd., Fuzhoushi | 2015
Out-of-stock
Kevin A. Gonzalez
Animal Drugs & Feed Form 483
FDA 483 Jiangsu Tianhe Pharmaceutical Co., Yangzhoushi | 2015
Out-of-stock
Kevin A. Gonzalez
Animal Drugs & Feed Form 483
FDA 483 Jiangxi Guoyao Pharmaceutical, LLC, Co., Nanchang | 2015
Out-of-stock
Kevin A. Gonzalez
Animal Drugs & Feed Form 483
FDA 483 Brightgene Bio-Medical Technology, Suzhou | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 BrightGene Pharmaceutical Co., Ltd., Suzhou | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 SM Biomed Sdn Bhd, Sungai Petani | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 SM Biomed Sdn Bhd, Sungai Petani, Kedah | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Yonezawa Hamari Chemicals, Ltd., Yonezawa, Yamagata | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Yonezawa Hamari Chemicals, Ltd., Yonezawa | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Fresenius Kabi USA, LLC, Grand Island | 2013
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Ebewe Pharma Ges MBH Nfg KG, Unterach am Attersee | 2012
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Luitpold Pharmaceuticals, Inc., Shirley | 2012
Out-of-stock
Kevin A. Gonzalez
Animal Drugs & Feed Form 483
FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2012
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Boehringer Ingelheim Pharma Gmbh & Co Kg, Biberach An Der Riss | 2012
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Merck Sharp& Dohme (Singapore), Ltd., Singapore | 2011
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
FDA 483 Parnell Manufacturing Pty, Ltd., Alexandria | 2011
Out-of-stock
Kevin A. Gonzalez
Animal Drugs & Feed Form 483
FDA 483 Luitpold Pharmaceuticals, Inc., Shirley | 2011
Out-of-stock
Kevin A. Gonzalez
Human Drug Form 483
Co-Investigators (41)
- Karen L. Kosar, FDA Investigator
- James D. Bridges, FDA Investigator
- Jose A. Lopez Rubet, FDA Investigator
- Lopez Rubet, Jose A, FDA Investigator
- Demitria J. Xiradakis, FDA Investigator
- Felix Maldonado, FDA Investigator
- Helen B. Ricalde, FDA Investigator
- Eric J. Reisenauer, FDA Investigator
- Chad N. Thompson, FDA Investigator
- Iraida Ortiz, FDA Investigator
- Alice S. Tsao, FDA Investigator
- Karl Auguste, FDA Investigator
- Carla A. Norris, FDA Investigator
- Javier O. Vega, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Ginger M. Sykes, FDA Investigator
- Donna M. Williams Hill, FDA Investigator
- Williams Hill, Donna M, FDA Investigator
- Amy W. Yan Mai, FDA Investigator
- Yan Mai, Amy W, FDA Investigator
- Alia Legaux, FDA Investigator
- Paul C. Mouris, FDA Investigator
- Parul M. Patel, FDA Investigator
- Gary J. Lehr, FDA Investigator
- Robert C. Steyert, FDA Investigator
- Steven M. Weinman, FDA Investigator
- Matthew A. Spataro, FDA Investigator
- Robert C. Horan, FDA Investigator
- Arduino Frankovic, FDA Investigator
- Michael R. Dominick, FDA Investigator
- Charisse K. Green, FDA Investigator
- Andrew F. Cohen, FDA Investigator
- Lisa Mathew, FDA Investigator
- Uduak M. Inokon, FDA Investigator
- James A. Liubicich, FDA Investigator
- Joyce A. Williams, FDA Investigator
- Eufemia G. Gonzalez, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Barbara D. Paul, FDA Investigator
- Sandra D. Thompson, FDA Investigator
- Peter R. Caparelli, FDA Investigator